Synthesis of a ring-expanded bryostatin analogue

Journal of the American Chemical Society

Volumn 129, Issue 8, 2007, Pages 2206-2207

  Trost, Barry M ^a   Yang, Hanbiao ^a   Thiel, Oliver R ^a   Frontier, Alison J ^a   Brindle, Cheyenne S ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN; BRYOSTATIN DERIVATIVE; NATURAL PRODUCT; RUBIDIUM; TETRAHYDROPYRAN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; STRUCTURE ACTIVITY RELATION;

CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MACROLIDES; MOLECULAR CONFORMATION; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33847638397     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja067305j     Document Type: Article

References (37)

1. For a recent review, see: Hale, K. J.; Hummersone, M. G.; Manaviazar, S.; Frigerio, M. Nat. Prod. Rep. 2002, 19, 413.
2. (a) El-Rayes, B. F.; Gadgeel, S.; Shields, A. F.; Manza, S.; Lorusso, P.; Philip, P. A. Clin. Cancer Res. 2006, 12, 7059.
3. (b) Pagliaro, L. C.; Perez, C. A.; Tu, S.-M.; Daliani, D. D. Urol. Oncol.: Semin. Orig. Invest. 2006, 24, 487 and references therein.
4. For recent examples, see: (a) Wender, P. A.; Horan, J. C.; Verma, V. A. Org. Lett. 2006, 8, 5299.
5. (b) Wender, P. A.; Horan, J. C. Org. Lett. 2006, 8, 4581.
6. (c) Keck, G. E.; Welch, D. S.; Vivian, P. K. Org. Lett. 2006, 8, 3667.
7. (d) Keck, G. E.; Truong, A. P. Org. Lett. 2005, 7, 2153.
8. (e) Cho, C.-W.; Krische, M. J. Org. Lett. 2006, 8, 891.
9. (f) Ball, M.; Bradshaw, B. J.; Dumeunier, R.; Gregson, T. J.; MacCormick, S.; Omori, H.; Thomas, E. J. Tetrahedron Lett. 2006, 47, 2223.
10. (g) Voight, E. A.; Seradj, H.; Roethle, P. A.; Burke, S. D. Org. Lett. 2004, 6, 4045.
11. Kageyama, M.; Tamura, T.; Nantz, M. H.; Roberts, J. C.; Somfai, P.; Whritenour, D. C.; Masamune, S. J. Am. Chem. Soc. 1990, 112, 7407.
12. (a) Evans, D. A.; Carter, P. H.; Carreira, E. M.; Prunet, J. A.; Charette, A. B.; Lautens, M. Angew. Chem., Int. Ed. 1998, 37, 2354.
13. (b) Evans, D. A.; Carter, P. H.; Carreira, E. M.; Charette, A. B.; Prunet, J. A.; Lautens, M. J. Am. Chem. Soc. 1999, 121, 7540.
14. Ohmori, K.; Ogawa, Y.; Obitsu, T.; Ishikawa, Y.; Nishiyama, S.; Yamamura, S. Angew. Chem.. Int. Ed. 2000, 39, 2290.
15. Manaviazar, S.; Frigerio, M.; Bhatia, G. S.; Hummersone, M. G.; Aliev, A. E.; Hale, K. J. Org. Lett. 2006, 8, 4477.
16. Wender, P. A.; Baryza, J. L.; Bennett, C. E.; Bi, F. C.; Brenner, S. E.; Clarke, M. O.; Horan, J. C.; Kan, C.; Lacote, E.; Lippa, B.; Nell, P. G.; Turner, T. M. J. Am. Chem. Soc. 2002, 124, 13648.
17. Trost, B. M.; Yang, H.; Wuitschik, G. Org. Lett. 2005, 7, 4761.
18. Trost, B. M.; Frontier, A. J. J. Am. Chem. Soc. 2000, 122, 11727.
19. The Julia olefination, a well-established method in the previous three total syntheses for the construction of the macrocycle, is unlikely to work for our system due to the basicity of this procedure; see ref 5b.
20. For a recent review, see: Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem., Int. Ed. 2005, 44, 4490.
21. Our efforts to construct the bryostatin macrocycle via a RCM reaction met with no success; details will be reported in full account of our work. For another RCM approach by Thomas and co-workers, see ref 3f.
22. (a) Shiina, I.; Shibata, J.; Ibuka, R.; Imai, Y.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 2001, 74, 113.
23. (b) Blakemore, P. R.; Browder, C. C.; Hong, J.; Lincoln, C. M.; Nagornyy, P. A.; Robarge, L. A.; Wardrop, D. J.; White, J. D. J. Org. Chem. 2005, 70, 5449.
24. Evans, D. A.; Chapman, K. T.; Carreira, E. M. J. Am. Chem. Soc. 1988, 110, 3560.
25. Otera, J.; Yano, T.; Kawabata, A.; Nozaki, H. Tetrahedron Lett. 1986, 27, 2383.
26. Roy, R.; Rey, A. W.; Charron, M.; Molino, R. Chem. Commun. 1989, 1308.
27. Synthesized in three steps from 3-methyl-2-butanone. See Supporting Information for details.
28. 2-catalyzed cycloisomerization was performed. See Supporting Information for details.
29. Dess, D. B.; Martin, J. C. J. Am. Chem. Soc. 1991, 113, 7277.
30. Luche, J. L.; Rodriguez-Hahn, L.; Crabbe, P. Chem. Commun. 1978, 601.
31. Takai, K.; Nitta, K.; Utimoto, K. J. Am. Chem. Soc. 1986, 108, 7408.
32. Negishi, E. Acc. Chem. Res. 1982, 15, 340.
33. Shiina, I.; Kubota, M.; Oshiumi, H.; Hashizume, M. J. Org. Chem. 2004, 69, 1822.
34. Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168.
35. Under this and several other conditions, relay ring-closing metathesis (RRCM) did not occur. For a leading reference on RRCM, see: Hoye, T. R.; Jeffrey, C. S.; Tennakoon, M. A.; Wang, J.; Zhao, H. J. Am. Chem. Soc. 2004, 126, 10210.
36. 50 values of 10 and 240 nM, respectively, in the same assay; see: (a) Hearn, B. R.; Zhang, D.; Li, Y.; Myles, D. C. Org. Lett. 2006, 8, 3057.
37. (b) Shaw, S. J.; Sundermann, K. F.; Burlingame, M. A.; Myles, D. C.; Freeze, B. S.; Xian, M.; Brouard, I.; Smith, A. B., III. J. Am. Chem. Soc. 2005, 127, 6532.